Refine your search:     
Report No.

Conceptual plan of radiopharmaceutical production process in JMTR

Iimura, Koichi ; Sakamoto, Taichi; Kanno, Masaru; Hori, Naohiko 

At Oarai Research and Development Center, Japan Atomic Energy Agency (JAEA) advances the plan of refurbishing Japan Materials Testing Reactor (JMTR) to start the operation in fiscal 2011. As part of effective use for JMTR, JAEA is planning to product $$^{99}$$Mo, which is a parent nuclide of $$^{rm 99m}$$Tc. $$^{rm 99m}$$Tc is most commonly used as a radiopharmaceutical in the field of nuclear medicine. Currently the supplying of $$^{99}$$Mo is only depend on imports from foreign countries, so JAEA is aiming at domestic production of a part of $$^{99}$$Mo in cooperation with the industrial circles. In this article, JAEA introduced the Conceptual Plan about the choice and fabric of the irradiation facilities for $$^{99}$$Mo production, and commercializing equipment after irradiation for $$^{99}$$Mo production.



- Accesses





[CLARIVATE ANALYTICS], [WEB OF SCIENCE], [HIGHLY CITED PAPER & CUP LOGO] and [HOT PAPER & FIRE LOGO] are trademarks of Clarivate Analytics, and/or its affiliated company or companies, and used herein by permission and/or license.